Form 4 for BIOA BioAge Labs, Inc.
Accepted 2026-07-01 16:27:06 ET · period of report 2026-06-29 · accession 0001836297-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-01 16:27 | 2026-06-29+ | BIOA | Barton Shane | Principal Accounting Off | M - OptEx | $6.58 | +59.9K | 20.2K | New | +$394.6K |
| DMT | 2026-07-01 16:27 | 2026-06-29+ | BIOA | Barton Shane | Principal Accounting Off | S - Sale+OE | $25.20 | -62.6K | 0 | -100% | -$1.58M |
| DMT | 2026-07-01 16:27 | 2026-06-29+ | BIOA | Barton Shane | Principal Accounting Off | M - OptEx | $0.00 | -59.9K | 67.9K | -47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-29 | M | A | 9,301 | $10.85 | 11,933 | D | — | — | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. |
| 2 | Common | Common Stock | 2026-06-29 | M | A | 7,261 | $8.39 | 19,194 | D | — | — | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. |
| 3 | Common | Common Stock | 2026-06-29 | M | A | 8,958 | $4.30 | 28,152 | D | — | — | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. |
| 4 | Common | Common Stock | 2026-06-29 | M | A | 14,198 | $4.38 | 42,350 | D | — | — | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. |
| 5 | Common | Common Stock | 2026-06-29 | S | D | 42,350 | $25.21 | 0 | D | — | — | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.79 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. |
| 6 | Common | Common Stock | 2026-06-30 | M | A | 4,290 | $10.85 | 4,290 | D | — | — | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. |
| 7 | Common | Common Stock | 2026-06-30 | M | A | 4,000 | $8.39 | 8,290 | D | — | — | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. |
| 8 | Common | Common Stock | 2026-06-30 | M | A | 4,065 | $4.30 | 12,355 | D | — | — | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. |
| 9 | Common | Common Stock | 2026-06-30 | M | A | 7,861 | $4.38 | 20,216 | D | — | — | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. |
| 10 | Common | Common Stock | 2026-06-30 | S | D | 20,216 | $25.19 | 0 | D | — | — | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.42 per share, inclusive. |
| 11 | Derivative | Stock Option (Right to Buy) | 2026-06-29 | M | D | 9,301 | $0.00 | 17,589 | D | $10.85 · — to 2033-09-26 | 9,301 Common Stock | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. (F4) The option vested as to 1/4th of the total award on September 25, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |
| 12 | Derivative | Stock Option (Right to Buy) | 2026-06-29 | M | D | 7,261 | $0.00 | 21,016 | D | $8.39 · — to 2034-04-16 | 7,261 Common Stock | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. (F5) The option vested as to 1/4th of the total award on October 17, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |
| 13 | Derivative | Stock Option (Right to Buy) | 2026-06-29 | M | D | 8,958 | $0.00 | 31,042 | D | $4.30 · — to 2034-12-17 | 8,958 Common Stock | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. (F6) The option vested as to 1/4th of the total award on October 26, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |
| 14 | Derivative | Stock Option (Right to Buy) | 2026-06-29 | M | D | 14,198 | $0.00 | 75,802 | D | $4.38 · — to 2035-02-17 | 14,198 Common Stock | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. (F7) The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |
| 15 | Derivative | Stock Option (Right to Buy) | 2026-06-30 | M | D | 4,290 | $0.00 | 13,299 | D | $10.85 · — to 2033-09-26 | 4,290 Common Stock | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. (F4) The option vested as to 1/4th of the total award on September 25, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |
| 16 | Derivative | Stock Option (Right to Buy) | 2026-06-30 | M | D | 4,000 | $0.00 | 17,016 | D | $8.39 · — to 2034-04-16 | 4,000 Common Stock | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. (F5) The option vested as to 1/4th of the total award on October 17, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |
| 17 | Derivative | Stock Option (Right to Buy) | 2026-06-30 | M | D | 4,065 | $0.00 | 26,977 | D | $4.30 · — to 2034-12-17 | 4,065 Common Stock | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. (F6) The option vested as to 1/4th of the total award on October 26, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |
| 18 | Derivative | Stock Option (Right to Buy) | 2026-06-30 | M | D | 7,861 | $0.00 | 67,941 | D | $4.38 · — to 2035-02-17 | 7,861 Common Stock | (F1) The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. (F7) The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |